The First Affiliated Hospital of Xinxiang Medical College
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1950-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.gy120.net/
Clinical Trials
22
Active:0
Completed:1
Trial Phases
4 Phases
Phase 1:1
Phase 2:4
Phase 3:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Not Applicable
9 (60.0%)Phase 2
4 (26.7%)Phase 1
1 (6.7%)Phase 3
1 (6.7%)Assessment of the Dose Safety and Efficacy of Serine Combined With Fluorouracil Drugs
Not Applicable
Not yet recruiting
- Conditions
- Advanced Colorectal Cancer
- Interventions
- Drug: Serine（Oral）Drug: Fluoropyrimidine Drugs
- First Posted Date
- 2025-09-17
- Last Posted Date
- 2025-09-17
- Target Recruit Count
- 20
- Registration Number
- NCT07178613
AI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001)
Not Applicable
Not yet recruiting
- Conditions
- Oncological Comorbidities (e. g. Hypertension, Diabetes, Malnutrition)
- First Posted Date
- 2025-08-22
- Last Posted Date
- 2025-08-22
- Target Recruit Count
- 5000
- Registration Number
- NCT07136727
- Locations
- 🇨🇳
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
Not yet recruiting
- Conditions
- LeukemiaLymphoma
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Target Recruit Count
- 200
- Registration Number
- NCT07131449
Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting
Not Applicable
Not yet recruiting
- Conditions
- Malignant Solid TumorsModerate to High Emetogenic Chemotherapy (MEC/HEC) Drugs
- Interventions
- Combination Product: high antiemetic regimenCombination Product: moderate antiemetic regimenDrug: Medroxyprogesterone acetate oral suspension
- First Posted Date
- 2025-08-15
- Last Posted Date
- 2025-08-15
- Target Recruit Count
- 126
- Registration Number
- NCT07124195
- Locations
- 🇨🇳
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, China
Clinical Transformation of Bone Reconstruction With Autologous Bone Marrow Mesenchymal Stem Cells in Vitro to Repair Avascular Necrosis of Femur Head
Not Applicable
Not yet recruiting
- Conditions
- Avascular Necrosis of Femur Head
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Target Recruit Count
- 30
- Registration Number
- NCT07101562
- Locations
- 🇨🇳
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, Henan, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
News
No news found